Effect of a short-term walking after meals in improving gastrointestinal symptoms in individuals with functional abdominal bloating

Not Applicable

Conditions: Functional Abdominal Bloating.
Abdominal distension (gaseous)
R14.0

Registration Number: IRCT20200310046739N1

Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 100

Inclusion Criteria

Patients who meet the Rome IV criteria as diagnostic criteria for functional bloating/distension are included in the study

Exclusion Criteria

Patients with history of anorexia, weight loss, alteration in bowel habit, chronic diarrhea and upper/lower gastrointestinal bleeding over the past 3 months are excluded from the study
Patients with alarming points in physical examination including jaundice, organomegaly, ascites and temporal wasting are excluded
Individuals are not included in the study if they had any abnormal laboratory workup indicating an underlying disorder, body mass index =40, a history of GI or abdominopelvic surgery or significant coexisting medical condition or medications that affect GI tract motility
Furthermore, those subjects that were pregnant are excluded from the study

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Belching. Timepoint: Before intervention and 4 weeks after study intervention. Method of measurement: Using a 5-point Likert scale (1=very mild, 2=mild, 3=moderate, 4=severe, 5=very severe).;Postprandial epigastric fullness/bloating. Timepoint: Before intervention and 4 weeks after study intervention. Method of measurement: Using a 5-point Likert scale (1=very mild, 2=mild, 3=moderate, 4=severe, 5=very severe).;Abdominal discomfort/pain. Timepoint: Before intervention and 4 weeks after study intervention. Method of measurement: Using a 5-point Likert scale (1=very mild, 2=mild, 3=moderate, 4=severe, 5=very severe).;Flatus. Timepoint: Before intervention and 4 weeks after study intervention. Method of measurement: Using a 5-point Likert scale (1=very mild, 2=mild, 3=moderate, 4=severe, 5=very severe).

Secondary Outcome Measures